A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

Clinical trial NCT02528747 · COMPLETED

Trial details

NCT number: NCT02528747
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2009-01-01
Primary completion: 2011-12-01
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.